Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 12.65
-0.35 (-2.69%)
Aug 21, 2026, 3:00 PM CST
Jinyu Bio-technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,494 | 1,343 | 1,225 | 1,508 | 1,485 | 1,754 |
Other Revenue | 38.85 | 53.76 | 30.13 | 89.92 | 43.97 | 22.64 |
| 1,533 | 1,396 | 1,255 | 1,598 | 1,529 | 1,776 | |
Revenue Growth | 21.37% | 11.23% | -21.45% | 4.55% | -13.94% | 12.29% |
Cost of Revenue | 726.64 | 665.07 | 597.17 | 668.1 | 697.3 | 688.81 |
Gross Profit | 806.64 | 731.35 | 658.29 | 930.13 | 831.37 | 1,088 |
Selling, General & Admin | 522.1 | 525 | 432.34 | 491.55 | 421.77 | 501.9 |
Research & Development | 106.03 | 131.09 | 136.82 | 143.47 | 133.78 | 165.94 |
Other Operating Expenses | 54 | 23.36 | 21.83 | 23.14 | 22.26 | 24.5 |
Operating Expenses | 746.86 | 727.63 | 621.1 | 681.43 | 579.36 | 693.32 |
Operating Income | 59.78 | 3.72 | 37.19 | 248.7 | 252.01 | 394.19 |
Interest Expense | - | -0.47 | -5.5 | -0.05 | -4.81 | -0.04 |
Interest & Investment Income | 32.91 | 51.17 | 55.36 | 56.52 | 50.91 | 47.57 |
Currency Exchange Gain (Loss) | -0.1 | -0.43 | 0.05 | -0.02 | 0.08 | -0.05 |
Other Non Operating Income (Expenses) | -0.64 | -2.85 | -0.58 | 0.15 | 0.21 | -0.76 |
EBT Excluding Unusual Items | 91.95 | 51.14 | 86.52 | 305.28 | 298.39 | 440.91 |
Impairment of Goodwill | - | - | -3.21 | -18.08 | -65.02 | -39.75 |
Gain (Loss) on Sale of Investments | -26.67 | -4.01 | -9.49 | -7.78 | -9.81 | -3.22 |
Gain (Loss) on Sale of Assets | 8.72 | 8.38 | 2.58 | -0.04 | -0.04 | -2.31 |
Asset Writedown | -2.91 | -2.91 | -11.11 | -5.34 | -1.54 | -1.99 |
Other Unusual Items | 90 | 52.02 | 59.63 | 41.78 | 23.61 | 19.65 |
Pretax Income | 161.1 | 104.62 | 124.91 | 315.83 | 245.58 | 413.27 |
Income Tax Expense | 12.84 | 9.11 | 20.76 | 38.73 | 45.46 | 24.27 |
Earnings From Continuing Operations | 148.26 | 95.51 | 104.15 | 277.1 | 200.12 | 389.01 |
Minority Interest in Earnings | -4.47 | 4.61 | 4.83 | 6.53 | 10.54 | -6.72 |
Net Income | 143.79 | 100.11 | 108.99 | 283.63 | 210.66 | 382.29 |
Net Income to Common | 143.79 | 100.11 | 108.99 | 283.63 | 210.66 | 382.29 |
Net Income Growth | 209.28% | -8.14% | -61.58% | 34.64% | -44.90% | -5.89% |
Shares Outstanding (Basic) | 1,129 | 1,112 | 1,090 | 1,091 | 1,109 | 1,124 |
Shares Outstanding (Diluted) | 1,129 | 1,112 | 1,090 | 1,091 | 1,109 | 1,124 |
Shares Change | 9.15% | 2.06% | -0.10% | -1.61% | -1.39% | -0.35% |
EPS (Basic) | 0.13 | 0.09 | 0.10 | 0.26 | 0.19 | 0.34 |
EPS (Diluted) | 0.13 | 0.09 | 0.10 | 0.26 | 0.19 | 0.34 |
EPS Growth | 183.36% | -10.00% | -61.54% | 36.84% | -44.12% | -5.56% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 143.28 | 194.69 | 199.89 | 141.67 | 154.54 | 160.4 |
Free Cash Flow Per Share | 0.13 | 0.17 | 0.18 | 0.13 | 0.14 | 0.14 |
Dividend Per Share | 0.037 | 0.037 | 0.030 | 0.080 | 0.060 | 0.110 |
Dividend Growth | 23.33% | 23.33% | -62.50% | 33.33% | -45.45% | -8.33% |
Gross Margin | 52.61% | 52.37% | 52.43% | 58.20% | 54.38% | 61.22% |
Operating Margin | 3.90% | 0.27% | 2.96% | 15.56% | 16.49% | 22.19% |
Profit Margin | 9.38% | 7.17% | 8.68% | 17.75% | 13.78% | 21.52% |
Free Cash Flow Margin | 9.34% | 13.94% | 15.92% | 8.86% | 10.11% | 9.03% |
EBITDA | 306.62 | 255.42 | 252.37 | 437.17 | 450.92 | 585.17 |
EBITDA Margin | 20.00% | 18.29% | 20.10% | 27.35% | 29.50% | 32.94% |
D&A For EBITDA | 246.84 | 251.7 | 215.18 | 188.47 | 198.91 | 190.98 |
EBIT | 59.78 | 3.72 | 37.19 | 248.7 | 252.01 | 394.19 |
EBIT Margin | 3.90% | 0.27% | 2.96% | 15.56% | 16.48% | 22.19% |
Effective Tax Rate | 7.97% | 8.71% | 16.62% | 12.26% | 18.51% | 5.87% |
Revenue as Reported | 1,533 | 1,396 | 1,255 | 1,598 | 1,529 | 1,776 |
Advertising Expenses | - | 205.95 | 162.42 | 179.06 | 166.38 | 241.94 |